NEW DELHI: Gene-based drugs could help lower cholesterol levels in patients with naturally high levels of the lipid in their blood, according to new studies published in the New England Journal of Medicine.
Researchers of the two studies said that the drugs can be given to patients by injection four times a year. The studies analyse the performance of two gene-based drugs plozasiran and zodasiran in early stage (phase-2b) clinical trials in terms of safety and efficacy.
These drugs are RNA-based, meaning they are made using small pieces of ribonucleic acid, which is present in all living organisms.
